Neostigmine Injection
Product Images NDC 71872-7178

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Neostigmine (NDC 71872-7178). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

10mgvial (10mgvial)

Neostigmine Methylsulfate Injection, USP 1 mg/mL in a 10 mL multi-dose vial label. The label indicates it is for intravenous use, with a total of 10 mg per vial. The product is identified with NDC 43598-529-11, manufactured by Gland Pharma Limited and distributed by Dr. Reddy's Laboratories Inc. Storage instructions and ingredient details including Phenol and Sodium Acetate are also shown.*

FDA Label Image

71872-7178-1 Pdp (71872 7178 1)

Neostigmine Methylsulfate Injection USP 10 mg/10 mL (1 mg/mL) in a 10 mL multi-dose vial. The label shows the NDC 71872-7178-1, indicates intravenous use, and includes storage instructions (20° to 25°C). Manufactured by Gland Pharma Limited, India, and repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ.*

FDA Label Image

Structure (Structure)

Chemical structure of Neostigmine, showing its molecular arrangement with functional groups including quaternary ammonium and sulfate ions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.